theory clinical_55_6
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  Pathogenic :: "entity ⇒ bool"
  PALB2 :: "entity ⇒ bool"
  BindingPartner :: "entity ⇒ bool"
  Encodes :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Localizes :: "event ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  Sites :: "entity ⇒ bool"
  Damage :: "entity ⇒ bool"
  DNA :: "entity ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"
  Links :: "event ⇒ bool"
  BRCA1 :: "entity ⇒ bool"
  HRRepair :: "entity ⇒ bool"
  Promotes :: "event ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  Homologous :: "entity ⇒ bool"
  Repair :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Homolog1 :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Joining :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  In :: "event ⇒ entity ⇒ bool"
  Loss :: "entity ⇒ bool"
  Localization :: "entity ⇒ bool"
  Disrupts :: "event ⇒ bool"
  Prevents :: "event ⇒ bool"
  Promoting :: "event ⇒ bool"
  HRR :: "entity ⇒ bool"
  Disruption :: "entity ⇒ bool"
  DueTo :: "entity ⇒ entity ⇒ bool"
  Performing :: "event ⇒ bool"
  Role :: "entity ⇒ bool"
  Action :: "entity ⇒ bool"

(* Explanation 1: A patient with a pathogenic mutation in PALB2 encodes a binding partner that localizes BRCA2 to sites of DNA damage and links BRCA1 and BRCA2 in HR repair and DNA damage. *)
axiomatization where
  explanation_1: "∃x y z w v e1 e2 e3. Patient x ∧ Mutation y ∧ Pathogenic y ∧ PALB2 y ∧ BindingPartner z ∧ Encodes e1 ∧ Agent e1 x ∧ Agent e1 z ∧ Localizes e2 ∧ Agent e2 z ∧ BRCA2 w ∧ Sites v ∧ Damage v ∧ DNA v ∧ To w v ∧ Links e3 ∧ Agent e3 z ∧ BRCA1 w ∧ HRRepair v ∧ Damage v ∧ DNA v"

(* Explanation 2: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. BRCA2 x ∧ Molecules y ∧ Undamaged y ∧ Homologous y ∧ Repair y ∧ RAD51 z ∧ Homolog1 z ∧ Humans w ∧ Promotes e1 ∧ Agent e1 x ∧ Joining e2 ∧ Agent e2 x ∧ Agent e2 y ∧ Via e2 z ∧ In e2 w"

(* Explanation 3: Loss of PALB2 disrupts the localization of BRCA2 to sites of DNA damage, which directly prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
axiomatization where
  explanation_3: "∀x y z w e1 e2 e3. Loss x ∧ PALB2 x ∧ Localization y ∧ BRCA2 y ∧ Sites z ∧ Damage z ∧ DNA z ∧ Disrupts e1 ∧ Agent e1 x ∧ Agent e1 y ∧ To y z ∧ Prevents e2 ∧ Agent e2 y ∧ Promoting e3 ∧ Agent e3 y ∧ Joining e3 ∧ Molecules w ∧ Undamaged w ∧ Homologous w ∧ Repair w ∧ HRR w"

(* Explanation 4: The disruption of BRCA2 localization due to the loss of PALB2 prevents BRCA2 from performing its role in HRR, specifically in joining undamaged repair molecules. *)
axiomatization where
  explanation_4: "∀x y z w e1 e2. Disruption x ∧ Localization y ∧ BRCA2 y ∧ Loss z ∧ PALB2 z ∧ DueTo x z ∧ Prevents e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Performing e2 ∧ Agent e2 y ∧ Role y ∧ HRR y ∧ Joining e2 ∧ Molecules w ∧ Undamaged w ∧ Repair w"

theorem hypothesis:
  assumes asm: "Loss x ∧ PALB2 x ∧ Action y ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z"
  (* Hypothesis: Loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR *)
  shows "∃x y z e1 e2. Loss x ∧ PALB2 x ∧ Action y ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z ∧ Prevents e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Joining e2 ∧ Agent e2 y ∧ Agent e2 z"
proof -
  (* From the premise, we have the known information about the loss of PALB2 and its relation to BRCA2 and repair molecules. *)
  from asm have "Loss x ∧ PALB2 x ∧ Action y ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z" by blast
  (* Explanation 3 states that the loss of PALB2 disrupts the localization of BRCA2, which prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
  (* This aligns with the logical relation Implies(D, E), where D is the loss of PALB2 disrupting BRCA2 localization, and E is the prevention of BRCA2's action in HRR. *)
  then have "Prevents e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Joining e2 ∧ Agent e2 y ∧ Agent e2 z" sledgehammer
  (* Therefore, we can conclude the hypothesis that the loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR. *)
  then show ?thesis <ATP>
qed

end
